WO2001036367A2 - Organic compounds - Google Patents
Organic compounds Download PDFInfo
- Publication number
- WO2001036367A2 WO2001036367A2 PCT/EP2000/011471 EP0011471W WO0136367A2 WO 2001036367 A2 WO2001036367 A2 WO 2001036367A2 EP 0011471 W EP0011471 W EP 0011471W WO 0136367 A2 WO0136367 A2 WO 0136367A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- phenyl
- hydrogen
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/62—Halogen-containing esters
- C07C69/65—Halogen-containing esters of unsaturated acids
Definitions
- the present invention relates to the preparation of new compounds of formula I below that are suitable for controlling ectoparasites on domestic animals, productive livestock and pets. It relates to the preparation of those compounds and to their use in parasite control, and also to ectoparasiticidal compositions for use on domestic animals, productive livestock and pets, the compositions comprising at least one such compound as active ingredient, and to the use of such substances in the preparation of the said compositions.
- X is hydrogen, halogen, phenyl or C ⁇ . 4 alkyl
- Y is fluorine or chlorine
- A is -O-, -S- or -N(R 1 )-, wherein F is C ⁇ . alkyl, phenylthio or tolylthio n is from 1 to 12; m is from 2 to 6;
- R is hydrogen or one of the groups
- Het is a saturated or unsaturated, 3- to 7-membered heterocyclic ring that optionally additionally comprises O or S as further hetero atom or the hetero group -N(C ⁇ -6 alkyl)-;
- Aryl is phenyl or naphthyl; and R , R 3 , R 4 , R 5 , R 6 , R. and R 8 are each independently of the others hydrogen, C ⁇ . alkyl, C ⁇ - alkoxy, C 1-4 alkylthio, C ⁇ . 4 haloalkyl, C 2-6 alkenyl, C 2 .
- a heterocyclic ring in the context of R is an aliphatic or aromatic cyclic radical comprising at least one oxygen, sulfur or nitrogen atom.
- halogen in that case being fluorine, chlorine or bromine, but especially chlorine.
- heterocycles special preference is given to pyridine, thiazole, tetrahydrofuran and tetrahydropyran, especially tetrahydropyran.
- the number of substituents in the heterocycles cannot, of course, exceed the number of possible substitutions. For example, an oxirane radical bonded by way of carbon can naturally have only one substituent.
- Alkyl on its own or as a constituent of a haloalkyl, alkoxy or haloalkoxy radical is to be understood as meaning a saturated, unbranched or branched hydrocarbon radical having from one to four carbon atoms, for example a substituent such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl.
- halo indicates that the substituent in question is partially or completely halogenated.
- haloalkyl - as a group perse or as a structural element of other groups and compounds, such as of haloalkoxy, - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF 2 or CF 3 ; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH 2 CF 3 , CF 2 CF 3 , CF 2 CCI 3 , CF 2 CHCI 2 , CF 2 CHF 2 , CF 2 CFCI 2 , CF 2 CHB.
- halo and halogen denote halogen atoms and are generally fluorine, chlorine, bromine or iodine, especially fluorine or chlorine; as a substituent of an alkyl group they denote especially fluorine, and as a substituent of a phenyl ring they denote especially chlorine.
- Alkenyl - as a group perse or as a structural element of other groups and compounds, such as of alkenyloxy, haloalkenyl or haloalkenyloxy - is, in each case giving due consideration to the number of carbon atoms contained in the group or compound in question, either straight-chained, e.g. vinyl, 1 -methylvinyl, allyl, 1-butenyl or 2-hexenyl, or branched, e.g. iso- propenyl.
- Alkynyl is, in each case giving due consideration to the number of carbon atoms contained in the group in question, either straight-chained, e.g. propargyl, 2-butynyl or 5-hexynyl, or branched, e.g. 2-ethynylpropyl or 2-propargylisopropyl.
- Aryl itself or as a moiety of a substituent is phenyl or naphthyl, especially phenyl, with aryl as a moiety of a substituent being either unsubstituted or mono- or poly- substituted by C ⁇ - 4 alkyl, C ⁇ . haloalkyl, C ⁇ - 4 alkoxy, d. haloalkoxy, halogen, cyano, hydroxy, amino or by nitro, wherein each poly-substitution is not limited to identical substituents, it being possible rather for there to be a mixture of substituents present.
- a preferred group of compounds in the context of formula I is formed by those compounds wherein X is hydrogen, halogen or methyl; Y is fluorine or chlorine; A is -O-, n is from 1 to 6;
- Another especially preferred group of compounds in the context of formula I is formed by the compounds wherein X is hydrogen, halogen or C 1-4 alkyl; Y is fluorine or chlorine; A is -O-; n is from 1 to 6; m is from 2 to 4;
- R is the group 3 , w ere n et s ox rane, aziridine, 2H-azepine, dioxolane, pyrrolidine, piperidine, morpholine, pyridine, pyrrole, furan, thiene, imidazole, tetrahydrofuran, tetrahydropyran, dihydrofuran, dihydropyran, isoxazole, oxazole, thiazole, oxazoline, oxazolidine, imidazoline, imidazolidine or dioxane; and R 2 and R 3 are each independently of the other hydrogen, halogen, hydroxy, cyano, nitro, phenyl, amino, C ⁇ .
- the present invention relates also to the preparation of compounds of formula I, which is carried out by reacting a compound of formula II
- X, Y and n are as defined for formula I and Q is hydroxy or halogen, preferably chlorine or bromine, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
- R, A and m are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen.
- reaction of II wherein Q is halogen with a compound of formula III is preferably carried out in an inert, hydroxyl-group-free solvent in the presence of an organic base, for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-diazabicyclo[2.2.2]octane (DABCO), 1 ,5- diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec-7-ene (1 ,5-5) (DBU).
- an organic base for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-d
- the reaction is generally carried out at temperatures of from -30°C to +70°C, preferably from -10°C to + 50°C.
- Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloro- ethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethylenes, benzene, toluene, xylenes, petroleum ether
- reaction of II wherein Q is hydroxy with a compound of formula III is advantageously carried out in the presence of water-removing reagents customary for esterification, for example in the presence of a carbodiimide [dicyclohexylcarbodiimide (DCC)] or of a 1 -alkyl- 2-halopyridinium salt, such as 1 -methyl-2-chloropyridinium iodide.
- DCC dicyclohexylcarbodiimide
- a 1 -alkyl- 2-halopyridinium salt such as 1 -methyl-2-chloropyridinium iodide.
- the reaction is in that case advantageously carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C, in the presence of a solvent or solvent mixture that is inert to the reaction.
- the reaction is preferably carried out in the presence of a base, for example in the presence of an organic amine, such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidino-pyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-ethylaniline).
- an organic amine such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidino-pyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N
- Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloroethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, - 6 -
- anisole, dioxane and tetrahydrofuran anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; and mixtures of such solvents with one another.
- the conversion of free compounds I into salts and of salts into free compounds I or into other salts is effected in customary manner, e.g. by treatment of a free compound I with an acid, or of a salt with a base.
- ectoparasites are understood to mean in particular insects, mites and ticks. Included are insects of the following orders: Lepidoptera, Coleoptera, Homoptera, Heteroptera, Diptera, Thysanoptera, Orthoptera, Psoroptes, Anoplura, Siphonaptera, Mallophaga, Thysanura, Isoptera, Psocoptera and Hymenoptera.
- ectoparasites that trouble humans and animals and transmit pathogens
- pathogens for example flies, such as Musca domestica, Musca vetustissima, Musca autumnalis, Fannia canicularis, Sarcophaga camaria, Lucilia cuprina, Hypoderma bovis, Hypoderma lineatum, Chrysomyia chloropyga, Dermatobia hominis, Cochliomyia hominivorax, Gasterophilus intestinalis, Oestrus ovis, Stomoxys calcitrans, Haematobia irritans and midges (Nematocera), such as Culicidae, Simuliidae, Psychodidae, and also bloodsucking parasites, for example fleas, such as Ctenocephalides felis and Ctenocephalides canis (cat and dog fleas), Xenopsylla cheopis, Pulex irritans, Dermatophilus pen
- ticks are, for example, Boophilus, Amblyomma, Anocentor, Dermacentor, Haemaphysalis, Hyalomma, Ixodes, Rhipicentor, Margaropus, Rhipicephalus, Argas, Otobius and Ornithodoros and the like that preferentially infest warm-blooded animals, including farm animals, such as cows, pigs, sheep and goats, poultry, such as hens, turkeys and geese, animals bred for their fur, such as mink, fox, chinchillas, rabbits and the like, and domestic animals, such as cats and dogs, but also humans.
- farm animals such as cows, pigs, sheep and goats
- poultry such as hens, turkeys and geese
- animals bred for their fur such as mink, fox, chinchillas, rabbits and the like
- domestic animals such as cats and dogs, but also humans.
- Ticks may be subdivided into hard and soft ticks and are characterised by the fact that they infest one, two or three host animals. They attach themselves to a suitable host animal and suck blood or body fluid. Fully replete female ticks fall off the host animal and lay large amounts of eggs (2000 to 3000) in a suitable niche in the ground or in any other protected site, where the larvae hatch out. These in turn look for a host animal from which to suck blood. Larvae of ticks that infest only one host animal moult twice and in so doing become nymphs and finally adult ticks without leaving the host animal initially selected. Larvae of ticks that infest two or three host animals fall off after the blood meal, moult in the surrounding area and, as nymphs or adult ticks, look for a second or third host on which to suck.
- Ticks are responsible worldwide for carrying and transmitting many human and animal diseases.
- the most significant ticks owing to their economic effect, are Boophilus, Rhipicephalus, Ixodes, Hyalomma, Amblyomma and Dermacentor. They are carriers of bacterial, viral, rickettsial and protozoal diseases and cause tick paralysis and tick toxicosis. Just a single tick can cause paralysis as a result of its saliva penetrating the host animal as the tick takes its nourishment. Diseases triggered by ticks are usually carried by ticks that infest a plurality of host animals.
- ticks are responsible for the death of, or injury to, a large number of domestic and farm animals worldwide.
- ixodid ticks transmit the agent of chronically damaging Lyme disease from wild animals to humans.
- ticks are responsible for large-scale economic loss in livestock production. The losses are attributable not only to the death of the host animals but also to damage to the coat, growth loss, reduction in milk production and the reduced value of the meat.
- fleas are not only a nuisance but are also disease carriers, which, especially in moist-warm climatic regions, for example in the Mediterranean region, the southern part of the USA, etc., transmit various fungal diseases from host animal to host animal and to the animal keeper. Especially at risk are people having a weakened immune system or children whose immune system has not yet fully developed.
- the present invention accordingly preferably relates to a method of controlling parasites on domestic animals, productive livestock and pets, which method comprises administering an effective amount of a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
- a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
- Pour-on and spot-on formulations are especially preferred forms of topical administration, but administration in the form of sprays, ointments, solutions, baths or powders may also be expedient.
- the compound of formula I according to the invention will normally be administered not in pure form but preferably in the form of a composition that comprises, in addition to the active ingredient, constituents that assist administration, suitable constituents being those which are tolerated by the host animal.
- the control according to the invention covers both the adult parasites and the juvenile stages of the parasites. Further active substances may of course be added to such compositions in order to broaden the spectrum of activity of the active ingredient.
- compositions to be administered in accordance with the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of a compound of formula I according to the invention and from 99.9 to 1% by weight, especially from 99.9 to 5% by weight, of a solid or liquid, physiologically tolerable carrier, including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
- a solid or liquid, physiologically tolerable carrier including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
- compositions may comprise further additives, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
- additives such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
- physiologically tolerable carriers known from veterinary medicinal practice for oral, percutaneous and topical administration can be used as formulation auxiliaries. Some examples are given below.
- Suitable carriers are especially fillers, such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate, and binders, such as starch pastes using, for example, maize, wheat, rice or potato starch, gelatins, tragacanth, methyl cellulose and/or, if desired, disintegrators, such as the above-mentioned starches, also carboxymethyl starch, crosslinked polyvinylpyrrolidone, agar, alginic acid or a salt thereof, such as sodium alginate.
- fillers such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate
- binders such as starch pastes using, for example, maize, wheat, rice or potato star
- Adjuvants are especially flow regulators and lubricants, for example silicic acid, talc, stearic acid or salts thereof, such as magnesium or calcium stearate, and/or polyethylene glycol.
- Dragee cores can be provided with suitable, optionally enteric, coatings, there being used, inter alia, concentrated sugar solutions which may comprise gum arabic, talc, polyvinylpyrrolidone, polyethylene glycol and/or titanium dioxide, or coating solutions in suitable organic solvents or solvent mixtures or, for the preparation of enteric coatings, solutions of suitable cellulose preparations, such as acetyl cellulose phthalate or hydroxypropylmethylcellulose phthalate. Dyes, flavourings or pigments may be added to the tablets or dragee coatings, for example for identification purposes or to indicate different doses of active ingredient.
- the preferred pour-on or spot-on method comprises applying the compound of formula I to a locally defined area of the skin or coat, advantageously on the back of the neck or the backbone of the animal. This is carried out, for example, by applying a swab or squirt of the pour-on or spot-on formulation to a relatively small area of the coat from where the active ingredient becomes distributed over a wide area of the coat almost automatically, as a result of the spreading constituents of the formulation and assisted by the movements of the animal.
- Pour-on and spot-on formulations advantageously comprise carriers that promote rapid distribution over the surface of the skin or in the coat of the host animal and are generally termed spreading oils.
- suitable oils for example, oily solutions; alcoholic and isopropanolic solutions, e.g.
- solutions of 2-octyldodecanol or oleyl alcohol solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, capric acid esters of saturated fatty alcohols of chain length C ⁇ 2 -C 18 ; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g.
- glycols may be advantageous for a dispersant known from the pharmaceutical or cosmetic industry also to be present.
- examples are pyrrolidin-2-one, N-alkylpyrrolidin-2-one, acetone, polyethylene glycol and its ethers and esters, propylene glycol and synthetic triglycerides.
- Th e oily solutions include e.g. vegetable oils, such as olive oil, groundnut oil, sesame oil, pine oil, linseed oil and castor oil. The vegetable oils may also be in epoxidised form. It is also possible to use paraffins and silicone oils.
- a pour-on or spot-on formulation will contain from 1 to 20% by weight of a compound of formula (I), from 0.1 to 50% by weight of dispersant and from 45 to 98.9% by weight of solvent.
- the pour-on or spot-on method can be used especially advantageously for herd animals, such as cattle, horses, sheep and pigs, where it is difficult or time-consuming to treat all the animals orally or via injection.
- this method can of course also be used for all other animals, including individual domestic animals and pets, and is very popular with the keepers of animals because it can often be carried out without the expert assistance of a veterinary surgeon.
- Dustable powders 25 parts by weight compound of formula I 1 part by weight sodium lauryl sulfate, 3 parts by weight colloidal silica gel, and 71 parts by weight urea.
- Suspension concentrates compound of formula I : from 5 to 75 %, preferably from 10 to 50 % water: from 94 to 24 %, preferably from 88 to 30 % surfactant: from 1 to 40 %, preferably from 2 to 30 %
- compositions may also comprise further additives, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and tackifiers, as well as fertilisers, or other active ingredients for obtaining special effects.
- stabilisers e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil)
- antifoams e.g. silicone oil
- preservatives e.g. silicone oil
- viscosity regulators e.g. binders and tackifiers
- fertilisers e.g., binders and tackifiers
- the compounds of formula I according to the invention can be used alone or in combination with other biocides.
- biocides for example, in order to enhance their effect they can be combined with pesticides having the same direction of action or in order to broaden the spectrum of activity they can be combined with substances having a different direction of action. It may also be advantageous to add repellents.
- the compounds of formula I are advantageously combined with substances having endoparasiticidal properties. They can, of course, also be used in combination with anti-bacterial compositions.
- the compounds of formula I are "adulticides", that is to say they are effective especially against the fully grown stages of the target parasites, it can be highly advantageous to add pesticides that attack the juvenile stages of the parasite as well. In that manner most of the parasites causing substantial economic damage are targeted. This also helps considerably in avoiding the development of resistance. Some combinations can also produce synergistic effects, which means that the total amount of active substance used can be reduced, which is desirable from the ecological standpoint. Preferred groups of combination partners and especially preferred combination partners are mentioned hereinbelow, it being possible for combinations to comprise, in addition to a compound of formula I, one or more such partners.
- Suitable mixing partners are biocides, such as the insecticides and acaricides mentioned hereinbelow that are sufficiently well known to the person skilled in the art and that have various action mechanisms, e.g. chitin synthesis inhibitors, growth regulators; active ingredients that act like juvenile hormones; active ingredients that act as adulticides; broad- spectrum insecticides, broad-spectrum acaricides and nematicides; and also the sufficiently well known anthelmintics and substances that repel insects and/or acarina, so-called repellents and detachers.
- suitable insecticides and acaricides are:
- LV a preparation comprising insect-active fungi
- LVI a preparation comprising insect-active viruses
- Non-limiting examples of suitable repelling substances are:
- XXXVI S-tert-butylthiomethyl 0,0-dimethyl phosphorodithioate (terbufos), from The Pesticide Manual, 1 1 ⁇ Ed. (1997), The British Crop Protection Council, London, page 1165;
- XXXVII ethyl (3-fert-butyl-1-dimethylcarbamoyl-1 H-1 ,2,4-triazol-5-yl-thio)-acetate, (triazamate), from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1224;
- Pesticide Manual 11 th Ed. (1997), The British Crop Protection Council, London, page 507;
- XLVII 4-phenoxyphenyl (f?S)-2-(pyridyloxy)propyl ether (pyriproxyfen), from The Pesticide
- (LIN) a preparation comprising insect-active nematodes, preferably Heterorhabditis bacteriophora and Heterorhabditis megidis, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 671 ; Steinernema feltiae, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1115, and Steinernema scapterisci, from The Pesticide Manual, 11 ,h Ed. (1997), The British Crop Protection Council, London, page 1116;
- LV a preparation comprising insect-active fungi, preferably Verlicillium lecanii, from The Pesticide Manual, 1 1 , Ed. (1997), The British Crop Protection Council, London, page 1266; Beauveria brogniartii, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 85; and Beauveria bassiana, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 83;
- LPI a preparation comprising insect-active viruses, preferably Neodipridon Sertifer NPV, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1342; Mamestra brassicae NPV, from The Pesticide Manual, 11 Ed. (1997), The British Crop Protection Council, London, page 759; and Cydia pomonella granulosis virus, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council,
- Crop Protection Council London, page 1094; and (CLXXXIII) ( ⁇ /'-[4-methoxy-biphenyl-3-yl]-hydrazinecarboxylic acid isopropyl ester (D 2341), from the Brighton Crop Protection Conference, 1996, 487- 493; (R2) Book of Abstracts, 212th ACS National Meeting Orlando, FL, August 25-29 (1996),
- a further substantial aspect of the present invention relates to combination preparations for the control of parasites in or on warm-blooded animals, which combination preparations comprise, in addition to a compound of formula I, at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier.
- the present invention is not limited to combinations of two constituents.
- erythrocytes aspartate aminotransferase (ASAT) haemoglobin (HB) alanine aminotransferase (ALAT) mean cell volume (HCT) creatine kinase (CK/NAC) mean cell-haemoglobin (MCH) ⁇ -glutamate transpeptidase (G-GT) mean cell-haemoglobin concentration total bilirubin (TBILI)
- MCHC leucocytes
- WBC creatinine
- CREA blood platelets
- PHT glucose
- GLUC glucose
- PHT glutamate dehydrogenase
- BUN blood-urea-nitrogen
- TOT. PROTEIN albumin
- ALB globulin
- GLOB globulin
- NA sodium
- K calcium
- CA calcium
- test substances do not at any time prove to cause local side- effects and the blood and chemical values measured show a range of variation absolutely identical to that for the untreated control animals.
- the compounds of formula I e.g. compounds nos. 1.1-1.8, 1.39 and 2.1 , prove to be well tolerated up to a dose of 100 mg/kg under the test conditions.
- Example 2 In vivo activity against mange mites on sheep after pour-on application Healthy sheep having an average body weight of approximately 35 kg are artificially infested, between the shoulder blades and in the groin area, with mange (Psoroptes ovis) of all stages of development. After 3 weeks, approximately 90% of the sheep have infested areas of skin of about 25 - 50 cm 2 . The infested sheep are selected for the remaining tests and, in order to be able to distinguish clearly between them, they are provided with numbered eartags. For the entire duration of the test, the sheep are kept in individual pens (0.9 x 1.2 m) having a slatted grid floor.
- Example 3 In vivo action against mouse mites by topical treatment
- mice infested with mites are anaesthetised and studied under a stereomicroscope to determine the density of the mite population.
- the mice are divided into groups having the same index of infestation, that is to say each having the same mite population, the index consisting of a scale from 1 (no mites) to 30 (greatest mite density). For the purposes of the test, only mice that score at least 25 on the said scale (high mite density) are used.
- the test substance is applied to the coat in the form of a solution, suspension or emulsion as a pour-on formulation, that is to say, topically.
- the dose is in the range from 32 to 0.1 mg/kg of body weight.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25068/01A AU2506801A (en) | 1999-11-19 | 2000-11-17 | Organic compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2116/99 | 1999-11-19 | ||
CH211699 | 1999-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001036367A2 true WO2001036367A2 (en) | 2001-05-25 |
WO2001036367A3 WO2001036367A3 (en) | 2001-11-08 |
Family
ID=4226258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/011471 WO2001036367A2 (en) | 1999-11-19 | 2000-11-17 | Organic compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2506801A (en) |
WO (1) | WO2001036367A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0432861A1 (en) * | 1989-12-15 | 1991-06-19 | Schering Aktiengesellschaft | Halogenated olefines, process for the preparation thereof and their use as pesticides |
EP0577555A1 (en) * | 1992-06-30 | 1994-01-05 | Ciba-Geigy Ag | Derivatives of carboxylic acids |
-
2000
- 2000-11-17 AU AU25068/01A patent/AU2506801A/en not_active Abandoned
- 2000-11-17 WO PCT/EP2000/011471 patent/WO2001036367A2/en active Search and Examination
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0432861A1 (en) * | 1989-12-15 | 1991-06-19 | Schering Aktiengesellschaft | Halogenated olefines, process for the preparation thereof and their use as pesticides |
EP0577555A1 (en) * | 1992-06-30 | 1994-01-05 | Ciba-Geigy Ag | Derivatives of carboxylic acids |
Also Published As
Publication number | Publication date |
---|---|
AU2506801A (en) | 2001-05-30 |
WO2001036367A3 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU762529B2 (en) | Pesticides | |
RU2259370C2 (en) | Aminoheterocyclamide derivatives eliciting pesticide activity | |
AU2005219559B2 (en) | Use of pyrimidine compounds in the preparation of parasiticides | |
US6620767B1 (en) | Pesticidal n-heteroaryl alpha-alkoximino-carboxamides | |
US6667326B1 (en) | Pesticidal aminoheterocyclamide compounds | |
WO2001036367A2 (en) | Organic compounds | |
WO2001036371A1 (en) | Carbonic acid derivatives and their use as ectoparasiticidal composition | |
WO2001036372A1 (en) | Organic compounds and their use in the control of ectoparasites | |
US20020173473A1 (en) | Organic compounds | |
ZA200103747B (en) | Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides. | |
WO2000042047A1 (en) | 4-phenoxymethyl-substituted milbemycins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |